Pfizer said on Thursday that finance chief Dave Denton will leave on August 15 to return to the consumer goods industry, after helping the U.S. drugmaker navigate its post-COVID transition.
The company named Cecile Guegan, senior vice president of finance for its global biopharmaceuticals business, as interim chief financial officer. Guegan has held a range of finance roles over 20 years at Pfizer.